作者：
Fysh,E.T.H. [1]
;
Tremblay,A. [2]
;
Feller-Kopman,D. [3]
;
Mishra,E.K. [4]
;
Slade,M. [5]
;
Garske,L. [6]
;
Clive,A.O. [7]
;
Lamb,C. [8]
;
Boshuizen,R. [9]
;
Ng,B.J. [10]
;
Rosenstengel,A.W. [11]
;
Yarmus,L. ;
Rahman,N.M. ;
Maskell,N.A. ;
GaryLee,Y.C.
作者单位：
Department of Thoracic Oncology, Papworth Hospital, Cambridge, United Kingdom
[1]
Netherlands Cancer Institute, Amsterdam, Netherlands
[2]
Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, United
[3]
Division of Respiratory Medicine, University of Calgary, Calgary, AB, Canada
[4]
Nepean Hospital Lung Cancer Multidisciplinary Group, Sydney, NSW, Australia
[5]
Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, United Kingdom
[6]
Division of Pulmonary and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, MD, United
[7]
Princess Alexandra Hospital, Brisbane, QLD, Australia
[8]
Pleural Diseases Unit, Sir Charles Gairdner Hospital, Perth, WA, Australia
[9]
Pleural Diseases Unit, Sir Charles Gairdner Hospital, Perth, WA, Australia, Centre for Asthma
[10]
Lahey Clinic, Burlington, MA, United States
[11]
发布时间
2014-01-21
换一批
